Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
NCT ID: NCT01002820
Description: None
Frequency Threshold: 0
Time Frame: Screening (0601 visit 12/last visit) through Visit 4 (week 56 - last visit)
Study: NCT01002820
Study Brief: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ganaxolone liquid suspension, 50 mg/mL, up to 500 mg/day TID or 1500 mg/day, up to 1 year 0 None 1 11 8 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Tension headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Transient ischemic attack SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Aortic aneurysm SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 9.0 View
Irritability SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Oedema Peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Nail Tinea SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Tinea Pedis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 9.0 View
Contusion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 9.0 View
Skin Laceration SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 9.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Complex Partial Seizures SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Intracranial Aneurysm SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Tension Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Transient Ischaemic Attack SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Menometrorrhagia SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 9.0 View
Rash Erythematous SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 9.0 View
Aortic Aneurysm SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 9.0 View